POLYSERP™ MENA
Broad-Spectrum 27-in-1 Snakebite Treatment for the Middle East, North Africa, and Central Asia
MIDDLE EAST, NORTH AFRICA
Single Source Treatment Option
POLYSERP MENA is a single source treatment option, covering 27 medically significant species in a single, broad-spectrum, freeze-dried formula. Designed for the field, POLYSERP is a safe, affordable, and effective treatment, bringing definitive care far-forward.
Indications
The low total protein content and patented purification, fragmentation and lyophilization process make POLYSERP among the safest products of its kind. POLYSERP MENA has a total incidence of possible severe early adverse reactions such as anaphylaxis of just 1%. POLYSERP is designed to be administered by direct IV push in low resource environments.
MENA
POLYSERP antivenoms are broad-spectrum, regionally specific formulations that have been carefully designed to meet the challenges of the austere medicine environment.
GET IN TOUCH
Contact us for more information.
For direct sales and quotes, contact our US-based team at sales@polyserptherapeutics.com.